Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies-Reference-Cited by-同舟云学术

Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies

Published:2015-12 Issue:6 Volume:29 Page:1107-1122
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Sze Henry,Blanchard Pierre,Ng Wai Tong,Pignon Jean-Pierre,Lee Anne W.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference70 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

2. Superiority of five year survival with chemoradiotherapy (CT-RT) vs radiotherapy in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: final report;Al-Sarraf;Proc Annu Meet Am Soc Clin Oncol,2001

3. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety;Wee;J Clin Oncol,2005

4. 4th FY Khoo Memorial Lecture 2008: Nasopharyngeal Cancer Workgroup–the past, the present and the future;Wee;Ann Acad Med Singapore,2008

5. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group;Lee;J Clin Oncol,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of adjuvant chemotherapy combined with concurrent chemoradiotherapy enhances survival rates in cases of locally advanced nasopharyngeal carcinoma;American Journal of Cancer Research;2024

2. Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission;Oral Oncology;2022-05

3. LncRNA HOTAIR regulates the expression of E-cadherin to affect nasopharyngeal carcinoma progression by recruiting histone methylase EZH2 to mediate H3K27 trimethylation;Genomics;2021-07

4. MiR-874-3p suppresses cell proliferation and invasion by targeting ADAM19 in nasopharyngeal carcinoma;Panminerva Medica;2021-06

5. Résultats thérapeutiques des carcinomes nasopharyngés: étude monocentrique à l´hôpital universitaire Fattouma Bourguiba de Monastir en Tunisie;Pan African Medical Journal;2021